Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101) Biophytis and Skyepharma, a French pharmaceutical company specializing in the formulation, development and production of pharmaceutical products, announce the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19, with a view to…
BIOPHYTIS ON THE STOCK MARKET
Biophytis has been listed on the market Euronext Growth Paris since July 13, 2015.
Type of listing: continuous
Number of outstanding shares: 658,916 ,59 (as of August 31, 2023)
1 ADR = 10 shares
Eligible for PEA and PEA-PME equity saving plans
Click here for live stock price